Locus Cell Co., Ltd. (TPEX:6891)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
77.30
+11.70 (17.84%)
Apr 28, 2026, 2:00 PM CST
252.16%
Market Cap 13.12B
Revenue (ttm) 12.74M
Net Income (ttm) -181.54M
Shares Out 200.05M
EPS (ttm) -0.91
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,078,246
Average Volume 2,414,667
Open 66.00
Previous Close 65.60
Day's Range 65.00 - 80.90
52-Week Range 20.70 - 80.20
Beta 0.56
RSI 89.04
Earnings Date Apr 30, 2026

About Locus Cell

Locus Cell Co., Ltd. focuses on contract development and manufacturing organization (CDMO) services for cell therapy related products in Taiwan and the United States. The company is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Yu-Hsiang Chang
Employees 53
Stock Exchange Taipei Exchange
Ticker Symbol 6891
Full Company Profile

Financial Performance

In 2025, Locus Cell's revenue was 12.74 million, an increase of 440.66% compared to the previous year's 2.36 million. Losses were -181.54 million, 60.6% more than in 2024.

Financial Statements

News

There is no news available yet.